Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23652627 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
Conditions: Glucose Transporter Type 1 Deficiency Syndrome;   Glut1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
2 Unknown  Post Study Continuation of C7 for G1D
Conditions: Glut1 Deficiency Syndrome;   Glucose Transporter Type 1 Deficiency Syndrome
Intervention: Drug: Triheptanoin

Study has passed its completion date and status has not been verified in more than two years.